Back to search results

OnTrackCF: App for Cystic Fibrosis Treatment Adherence

This study is looking at an app called OnTrackCF, which was created to help people with Cystic Fibrosis (CF) track their CFTR modulator therapy and symptoms. The goal is to see how easy the app is to use, how well people like it, and how much they use it. You can join if you are 18 or older, have CF, take a CFTR modulator twice a day, speak English, and have a smartphone or tablet with internet. The study plans to enroll 60 participants. Success will be measured by how usable and acceptable the app is to you, over a period of about one year.

Study design
This is a multi-site study that is not randomized, meaning participants are not assigned to groups by chance. It plans to include 60 adult participants with Cystic Fibrosis.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed through study completion, which is projected to be one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07031323

OnTrackCF: Engagement, Feasibility, and Acceptability Study

Recruiting
NAAges 18+Interventional
Boston Children's Hospital
~60 participants
Updated 2025-12-05 on ClinicalTrials.gov
What's tested:OnTrackCF

At a glance

Recruiting sites
1 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
System Usability Survey (SUS)
Measured over through study completion, projected to be 1 year
+1 more outcome measured

Conditions

Cystic Fibrosis (CF)
Cystic Fibrosis - Complete

Explore related trials

Cystic Fibrosis

Where it's being run

3 sites across 3 states
Alabama1
Maryland1
Massachusetts1

Study leadership

  • Kristin Riekert, PhD · PRINCIPAL_INVESTIGATOR · Johns Hopkins University
  • Gabriela Oates, PhD · PRINCIPAL_INVESTIGATOR · University of Alabama at Birmingham

Who to contact

Emma M McWilliams, BA
[email protected]
617-355-7534
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

What this trial measures

  • System Usability Survey (SUS)through study completion, projected to be 1 year

    By the last round of testing, the System Usability Survey (SUS) will have a median score of 75%.

  • Intervention Feasibility and Acceptability (iFAQ)through study completion, projected to be 1 year

    By the last round of testing, the Intervention Feasibility and Acceptability (iFAQ) OnTrackCF scales (Engagement, Feasibility, Acceptability, Usefulness, and Satisfaction) will each have a median score of ≥4 (out of 5).